TINNA P KING
Allopathic & Osteopathic Physicians|Internal Medicine CREVE COEUR, MO NPI 1932201092
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine MO IDORSIA PHARMACEUTICALS US INC All categories
General Payments — all program years on this page
$1,161.92
- Category: General Payments
- Program years: PY2018–2024
- Record count: 63
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $246.75 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $246.75 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| IDORSIA PHARMACEUTICALS US INC | $106.67 | 1 |
| ABBVIE INC. | $38.64 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $30.53 | 1 |
| Phathom Pharmaceuticals, Inc. | $20.58 | 1 |
| Novo Nordisk AS | $18.16 | 1 |
| SANOFI-AVENTIS U.S. LLC | $16.56 | 1 |
| Inspire Medical Systems, Inc. | $15.61 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1087142630 | Novartis Pharmaceuticals Corporation | $30.53 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097251738 | Novo Nordisk Inc | $18.16 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104078712 | ABBVIE INC. | $16.31 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104078714 | ABBVIE INC. | $22.33 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139637167 | SANOFI-AVENTIS U.S. LLC | $16.56 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1146753240 | IDORSIA PHARMACEUTICALS US INC | $106.67 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148068390 | Inspire Medical Systems, Inc. | $15.61 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151082381 | Phathom Pharmaceuticals, Inc. | $20.58 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.